Article
The prognostic value of Kirsten rat sarcoma viral oncogene homolog mutations in resected lung adenocarcinoma differs according to clinical features.
The Journal of thoracic and cardiovascular surgery - 1 Jan 2022
Ma Zelin, Zhang Yang, Deng Chaoqiang, Fu Fangqiu, Deng Lin, Li Yuan, Chen Haiquan
Abstract excerpt
BACKGROUND: The ninth edition of lung cancer staging system recommends that specific driver mutations should be considered as prognostic factors in survival models. This study comprehensively investigated the prognostic value of Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation in patien...
Topics
- Adenocarcinoma of Lung
- Biomarkers, Tumor
- China
- Female
- Humans
- Lung Neoplasms
- Male
- Middle Aged
- Mutation
- Neoplasm Invasiveness
- Neoplasm Staging
- Pneumonectomy
